SANFORD, N.C., Dec. 18 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth , announced today that the North Carolina Department of Labor (NCDOL) has recognized the Sanford vaccine manufacturing and research facility and the research facility in Research Triangle Park as Carolina STAR sites.
The Carolina STAR program is the Occupational Safety and Health Department’s most prestigious program for general industry. It recognizes work sites that are self-sufficient in their ability to control hazards through comprehensive and successful safety and health programs and acknowledges those sites as leaders in employee protection.
Cherie K. Berry, Commissioner, NCDOL, presented the award to the employees of the Sanford facility at a ceremony today. Wyeth’s research facility in Research Triangle Park received the award on November 6, 2007.
Nita Tosic, Managing Director, Wyeth, Sanford, says, “We are excited to be recognized with the Carolina STAR award and to be the first recipient among pharmaceutical manufacturers in the state. Our commitment to employee health and safety is steadfast, and we will continue to be active supporters of the state’s efforts with this program.”
Only 104 of the 230,000 employers in North Carolina have been recognized as Carolina STAR sites. Wyeth’s Sanford facility is the largest single-site employer to receive this honor.
Wyeth Pharmaceuticals, a division of Wyeth, has leading products in the areas of women’s health care, infectious disease, gastrointestinal health, central nervous system, inflammation, transplantation, hemophilia, oncology, vaccines and nutritional products.
Wyeth is one of the world’s largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products and non-prescription medicines that improve the quality of life for people worldwide. The Company’s major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.
CONTACT: Media: Wendy Kouba of Wyeth Pharmaceuticals, +1-484-865-5985; or
Investors: Justin Victoria of Wyeth, +1-973-660-5340
Web site: http://www.wyeth.com/
